Analystreport

Collegium Pharmaceutical Inc (NASDAQ: COLL) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com